Christopher Toombs
Director/Board Member at IKARIA, INC.
Profile
Christopher Toombs is the founder of Faraday Pharmaceuticals, Inc. (2014) and Proniras Corp.
(2018), where he holds the title of Chief Scientific Officer.
He is currently a Senior Director at Ikaria, Inc. (since 2006) and an Operating Partner at Accelerator Services Corp.
(current).
He was previously a Vice President at MuciMed, Inc. (2014-2016).
Dr. Toombs received a doctorate degree from Wake Forest School of Medicine in 1992 and an undergraduate degree from Wheaton College Graduate School in 1987.
Christopher Toombs active positions
| Companies | Position | Start |
|---|---|---|
| IKARIA, INC. | Director/Board Member | 2006-02-28 |
Faraday Pharmaceuticals, Inc.
 Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Founder | 2013-12-31 |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Founder | 2017-12-31 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Private Equity Investor | - |
Former positions of Christopher Toombs
| Companies | Position | End |
|---|---|---|
| MuciMed, Inc. | Private Equity Investor | 2016-06-29 |
Training of Christopher Toombs
| Wake Forest School of Medicine | Doctorate Degree |
| Wheaton College Graduate School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
| MuciMed, Inc. | |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Faraday Pharmaceuticals, Inc.
Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Health Technology |
Proniras Corp.
Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Christopher Toombs